UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Guidelines for the diagnosis and treatment of chronic heart failure

European heart journal, 2001-09, Vol.22 (17), p.1527-1560

2001

Volltextzugriff (PDF)

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

European heart journal, 2005-06, Vol.26 (11), p.1115-1140

2005

Volltextzugriff (PDF)

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

The New England journal of medicine, 1999-09, Vol.341 (10), p.709-717

1999

Volltextzugriff (PDF)

Die Güterschiffahrt auf der Saale und Unstrut

Remme, J

2020

Volltextzugriff (PDF)

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

The Lancet (British edition), 2003-07, Vol.362 (9377), p.7-13

2003

Volltextzugriff (PDF)

Comprehensive guidelines for the diagnosis and treatment of chronic heart failure Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology

European journal of heart failure, 2002-01, Vol.4 (1), p.11-22

2002

Volltextzugriff (PDF)

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

European heart journal, 2005-11, Vol.26 (21), p.2259-2268

2005

Volltextzugriff (PDF)

Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis

The American heart journal, 2015-12, Vol.170 (6), p.1092-1098

2015

Volltextzugriff (PDF)

Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure

Journal of the American College of Cardiology, 2000-11, Vol.36 (6), p.1903-1912

2000

Volltextzugriff (PDF)

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

Heart (British Cardiac Society), 2007-08, Vol.93 (8), p.968-973

2007

Volltextzugriff (PDF)

My Last Issue—a Farewell to Cardiovascular Drugs and Therapy

Cardiovascular drugs and therapy, 2019-12, Vol.33 (6), p.641-643

Remme, Willem J.

2019

Volltextzugriff (PDF)

Which Beta-Blocker is Most Effective in Heart Failure?

Cardiovascular drugs and therapy, 2010-08, Vol.24 (4), p.351-358

Remme, Willem J.

2010

Volltextzugriff (PDF)

Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians

European heart journal, 2008-07, Vol.29 (14), p.1739-1752

2008

Volltextzugriff (PDF)

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials

European heart journal, 2009-06, Vol.30 (11), p.1385-1394

2009

Volltextzugriff (PDF)

Medical misinformation: vet the message

Cardiovascular research, 2019-12, Vol.115 (14), p.e187-e188

2019

Volltextzugriff (PDF)

Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET

European journal of heart failure, 2007-09, Vol.9 (9), p.901-909

2007

Volltextzugriff (PDF)

Development and Validation of a Cardiovascular Risk Assessment Model in Patients With Established Coronary Artery Disease

The American journal of cardiology, 2013-07, Vol.112 (1), p.27-33

2013

Volltextzugriff (PDF)

The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy

European heart journal, 2005-07, Vol.26 (14), p.1369-1378

2005

Volltextzugriff (PDF)

A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET)

Journal of the American College of Cardiology, 2006-04, Vol.47 (8), p.1603-1611

2006

Volltextzugriff (PDF)

The sympathetic nervous system and ischaemic heart disease

European heart journal, 1998-06, Vol.19 (JUN), p.F62-F71

REMME, W. J

1998

Volltextzugriff (PDF)

Medical misinformation: Vet the message

Heart rhythm, 2019-03, Vol.16 (3), p.332-333

2019

Volltextzugriff (PDF)

Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study

Heart (British Cardiac Society), 2007-09, Vol.93 (9), p.1081-1086

2007

Volltextzugriff (PDF)

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

Journal of the American Heart Association, 2016-03, Vol.5 (3), p.e002688-n/a

2016

Volltextzugriff (PDF)

Medical Misinformation: Vet the Message

Journal of cardiovascular pharmacology, 2019-02, Vol.73 (2), p.61-62

2019

Volltextzugriff (PDF)

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

The American heart journal, 2005-02, Vol.149 (2), p.370-376

2005

Volltextzugriff (PDF)

1 – 25 von 651

Suche als RSS-Feed

Aktive Filter

SpracheNiederländisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(563)
Mit Volltextzugriff
(575)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(335)
Life Sciences & Biomedicine
(320)
Humans
(319)
Cardiovascular System & Cardiology
(201)
Cardiac & Cardiovascular Systems
(195)
Biological And Medical Sciences
(188)
Medical Sciences
(177)
Male
(154)
Female
(147)
Middle Aged
(122)
Aged
(100)
Animals
(93)
Pharmacology. Drug Treatments
(83)
Adult
(70)
Cardiovascular System
(70)
Cardiology. Vascular System
(66)
Heart
(65)
Pharmacology & Pharmacy
(57)
Angiotensin-Converting Enzyme Inhibitors - Therapeutic Use
(56)
Heart Failure - Drug Therapy
(56)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guidelines for the diagnosis and treatment of chronic heart failure

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Die Güterschiffahrt auf der Saale und Unstrut

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Comprehensive guidelines for the diagnosis and treatment of chronic heart failure Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis

Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

My Last Issue—a Farewell to Cardiovascular Drugs and Therapy

Which Beta-Blocker is Most Effective in Heart Failure?

Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials

Medical misinformation: vet the message

Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET

Development and Validation of a Cardiovascular Risk Assessment Model in Patients With Established Coronary Artery Disease

The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy

A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET)

The sympathetic nervous system and ischaemic heart disease

Medical misinformation: Vet the message

Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

Medical Misinformation: Vet the Message

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

Aktive Filter

Suchergebnisse filtern